1. Home
  2. ATAI vs HONE Comparison

ATAI vs HONE Comparison

Compare ATAI & HONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • HONE
  • Stock Information
  • Founded
  • ATAI 2018
  • HONE 1917
  • Country
  • ATAI Germany
  • HONE United States
  • Employees
  • ATAI N/A
  • HONE N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • HONE Major Banks
  • Sector
  • ATAI Health Care
  • HONE Finance
  • Exchange
  • ATAI Nasdaq
  • HONE Nasdaq
  • Market Cap
  • ATAI 444.7M
  • HONE 513.0M
  • IPO Year
  • ATAI 2021
  • HONE 2016
  • Fundamental
  • Price
  • ATAI $3.48
  • HONE $12.07
  • Analyst Decision
  • ATAI Strong Buy
  • HONE Buy
  • Analyst Count
  • ATAI 3
  • HONE 3
  • Target Price
  • ATAI $11.67
  • HONE $14.50
  • AVG Volume (30 Days)
  • ATAI 8.9M
  • HONE 247.7K
  • Earning Date
  • ATAI 08-12-2025
  • HONE 07-24-2025
  • Dividend Yield
  • ATAI N/A
  • HONE 2.99%
  • EPS Growth
  • ATAI N/A
  • HONE 71.76
  • EPS
  • ATAI N/A
  • HONE 0.65
  • Revenue
  • ATAI $1,863,000.00
  • HONE $164,819,000.00
  • Revenue This Year
  • ATAI $423.05
  • HONE N/A
  • Revenue Next Year
  • ATAI N/A
  • HONE $9.44
  • P/E Ratio
  • ATAI N/A
  • HONE $18.53
  • Revenue Growth
  • ATAI 572.56
  • HONE N/A
  • 52 Week Low
  • ATAI $1.03
  • HONE $8.89
  • 52 Week High
  • ATAI $4.00
  • HONE $13.73
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 60.69
  • HONE 51.69
  • Support Level
  • ATAI $3.06
  • HONE $11.97
  • Resistance Level
  • ATAI $3.70
  • HONE $12.42
  • Average True Range (ATR)
  • ATAI 0.27
  • HONE 0.26
  • MACD
  • ATAI 0.00
  • HONE -0.03
  • Stochastic Oscillator
  • ATAI 52.46
  • HONE 52.15

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About HONE HarborOne Bancorp Inc.

HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.

Share on Social Networks: